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CD8
+ cytotoxic T lymphocytes (CTLs) comprise an important host defense for controlling viral infections in humans. Chronic viral infections, such as those caused by human cytomegalovirus (HCMV), Epstein-Barr virus (EBV), and HIV-1, are characterized by the expansion of virus-specific CD8 + T cells [1] [2] [3] [4] [5] . The sustained presence of virus-specific CD8 + T cells is essential to keep virus replication in check, and loss of these cells is associated with renewed virus growth [6] [7] [8] . Murine studies have shown that, although CD4 + T cells may not be necessary for the induction of CD8 + T cell responses in acute viral infection [9] or first antigen (Ag) exposure [10] [11] [12] [13] , memory CD8 + T cells generated in the absence of CD4 + T cell help may be less capable of adequate subsequent expansion and that secondary ex-pansion of memory CD8 + T cells is otherwise not dependent on CD4 + T cell help [10] .
Exogenous protein Ags are processed by Ag-presenting cells and are presented via major histocompatibility complex class I (MHC-I) molecules to CD4 + T cells. Cross-presentation to CD8 + T cells can occur, however, when exogenous protein Ags gain access to the MHC-I pathway and are processed and presented via MHC-I molecules. Two routes of cross-presentation have been proposed. The first involves transfer of exogenous Ags from vacuolar compartments to the cytosol of Ag-presenting cells for processing and presentation in the conventional MHC-I pathway [14] . The second route involves vacuolar processing and presentation of Ags [15] [16] [17] [18] with peptides binding to MHC-I molecules either within vacuolar compartments or at the cell surface after recycling and regurgitation of peptides. These pathways have been well established in vitro, but direct evidence that this occurs in vivo during human viral infections is less clear. HCMV is a b-herpesvirus that establishes chronic infection after what is generally considered to be a clinically benign infection. Approximately 50% of healthy blood donors have serum IgG against HCMV. In HCMV-infected individuals, low-level persistent infection is thought to be controlled by virus-specific CD8 + T cells, and relatively large numbers of HCMV-specific CD8 + T cells persist during latent subclinical infection [19] [20] [21] [22] [23] [24] . Clinically apparent reactivation of HCMV rarely occurs, except in immunocompromised patients.
In the present study, we used dye-dilution techniques and flow cytometry to study in vitro memory CD8 + T cell expansion in response to HCMV Ags. CD8 + T cells from otherwise healthy HCMV-seropositive individuals proliferated after exposure to HCMV Ags, even in the absence of new viral protein synthesis. Using HCMV peptide-HLA class I tetrameric complexes [25] , in combination with other cell surface markers (CD8 and CD25), we visualized Ag-specific CD8 + T cell expansion. We found that CD8 + T cell expansion was entirely dependent on the presence of CD4 + T cells and was blocked by a monoclonal antibody (MAb) to IL-2. Exogenous IL-2 and/or IL-15 could replace the requirement for CD4 + T cells, but only MAb against IL-2 prevented Ag-driven CD8 + T cell proliferation in vitro. This system can be used to explore cooperation among CD4 + T cells, CD8 + T cells, and Ag-presenting cells that are permissive of memory CD8 + T cell expansion and cross-presentation in chronic viral infection.
MATERIALS AND METHODS

Cell preparation and culture conditions.
Blood from 7 healthy HCMV-seropositive blood donors was drawn into sodium heparin-containing Vacutainer tubes (Becton Dickinson). Peripheral blood mononuclear cells (PBMCs) were purified by Ficoll-Hypaque (Pharmacia) density sedimentation. PBMCs were either left unstained or immediately stained with 10 mmol of 5-(andϪ6) carboxyfluorescein diacetate succinimidyl ester (CFSE; Molecular Probes) for 10 min in PBS containing 0.1% bovine serum albumin (BSA) at 37ЊC. Cells were washed 3 times in RPMI 1640 medium (BioWhittaker) with 10% heat-inactivated fetal bovine serum (FBS; Summit Technologies). PBMCs were cultured in a 24-well tissue-culture plate (Falcon) at a concentration of 10 6 cells/mL in RPMI 1640 medium with 10 mmol of HEPES (BioWhittaker), 10 mmol of l-glutamine (BioWhittaker), 100 U/mL of penicillin, 100 mg/mL of streptomycin (BioWhittaker), and 10% heat-inactivated autologous serum.
Magnetic bead separations. CD8 + T cells were positively selected by use of magnetic beads (Dynal). In brief, PBMCs ( cells) were incubated with 144 mL of prewashed mouse 7 5 ϫ 10 anti-human CD8 microbeads at 4ЊC for 30 min with constant rotation/mixing. Bead-bound cells were isolated by magnetic separation, were washed 4 times with RPMI 1640 medium with 1% FBS, and were resuspended in 100 mL of RPMI 1640 medium with 1% FBS. Beads were detached by use of DETACHaBEAD, according to the manufacturer's instructions (Dynal), and were incubated for 1 h at room temperature with gentle mixing. In some experiments, CD14 + cells were removed by binding to mouse anti-human CD14 MicroBeads (Miltenyi Biotec), and CD4 + T cells were removed by binding to mouse anti-human CD4 MicroBeads (Miltenyi Biotec). Bead-bound cells were captured in a selection column attached to a magnet, whereas nonbead-bound cells were passed though the column.
In vitro proliferation of CFSE-labeled cells. To assess the responses to Ag stimulation, CFSE-labeled PBMCs were cultured with HCMV lysate (1:40 dilution; BioWhittaker); in some experiments, HCMV preparations were either exposed for 100 min to UV light in a tissue culture hood or boiled for 10 min to inactivate virus. An uninfected control lysate (HCMV control lysate; BioWhittaker) was used at the same dilution as the HCMV lysate (1:40 dilution). A murine anti-CD3 MAb (333 ng/mL; BD Pharmingen), tetanus toxoid (4 lfu/mL; Wyeth Ayerst), and HCMV pp65 [495] [496] [497] [498] [499] [500] [501] [502] [503] peptide NLVPMVATV (NLV9; Invitrogen) were used in some experiments to induce cellular proliferation. HCMV pp65 [495] [496] [497] [498] [499] [500] [501] [502] [503] peptide was dissolved in PBS (pH 7.2) and was used at a concentration of 10 mg/mL alone, in addition to other Ags, or supplemented with 3.6 IU/mL IL-2 (Chiron) or 10 ng/mL IL-15 (Immunex). Antibody-blocking experiments were performed by use of 1 mg/mL concentrations of MAbs directed against human (hu) IL-2 (clone 5334.21; R&D Systems) and against huIL-15 (clone 34505.11, R&D Systems) or an IgG1 isotype control (clone 11711.11; R&D Systems).
In some experiments, HCMV was purified from viral lysate. In brief, 1 mL of HCMV lysate was clarified by centrifugation for 20 min. Supernatant was overlayered onto a 60% sucrose (wt/wt) cushion. Virus was subjected to ultracentrifugation at 28,000 g for 1 h in a Beckman SW41Ti rotor at 4ЊC without braking. The virus band was removed, washed, resuspended in 1 mL of PBS, passed through a 0.45-mm filter (Millipore), and used at 1:40 dilution.
Cell surface and tetramer staining for flow cytometry. Cells were stained with 5 mL of CD4-allophycocyanin (APC; Becton-Dickenson), 10 mL of CD8-peridinin chlorophyll protein (PerCP; Becton-Dickenson), and 5 mL of CD25-phycoerythrin (PE; Immunotech) or 5 mL of IgG2a-PE isotype control (BD Pharmingen) for 10 min at room temperature. Cells were washed with PBS containing 1% BSA and 0.1% sodium azide (Sigma) and were fixed in PBS containing 1% paraformaldehyde (Electron Microscopy Science) before analysis.
To assess the frequency of tetramer-reactive CD8 + T cells, unlabeled PBMCs were stained immediately after Ficoll separation (or after cultivation) with 10 mL of CD8-PerCP, 5 mL of CD4-APC, and 10 mL of MHC-I HLA-A*0201 HCMV pp65 [495] [496] [497] [498] [499] [500] [501] [502] [503] (NLV9)-PE tetramer (Beckman Coulter Immunomics) or HLA-A*0201 EBV BMLF1 (GLCTLVAML)-PE tetramer (Beckman Coulter Immunomics) for 30 min at room temperature. Cells were washed with 4-mL PBS/BSA/azide solution, fixed with PBS/ BSA/paraformaldehyde solution, examined by use of a FACSCalibur flow cytometer (BD Immunocytometry Systems), and analyzed by use of CellQuest software.
After 8 days of antigenic stimulation, CFSE-labeled cells were examined, as described above. Typically, 10,000 total CD4 bright or CD8 +bright T cell events were collected. Cells were gated on side scatter versus CD4 +bright or CD8 +bright T cell staining. CD25 expression or tetramer binding and proliferation by CFSE dye dilution were determined in each of these populations. CD3 gating confirmed that 198% of the proliferating cells were T cells (data not shown). Flow cytometric analysis permitted discrimination of as many as 7 rounds of cell division, as ascertained by visual enumeration of the peaks that could be resolved after cells were stimulated with mitogen.
RESULTS
CD4
+ and CD8 + T cells proliferate in response to HCMV and tetanus toxoid Ag. PBMCs were cultured with HCMV or with tetanus toxoid. CD4
+ and CD8 + T cells (figures 1A and 1B, respectively) transiently expressed CD25 and then proliferated in response to both HCMV and tetanus toxoid Ags. Typically, CD4
+ T cells expressed CD25 by day 4, and proliferation was detected by this time ( figure 1A ). Evidence of Agspecific CD8 + T cell activation was delayed (figure 1B), but, by day 8, both CD4 + and CD8 + T cells responding to Ag stimulation had completed у7 rounds (the limit of resolution) of cell division and infrequently expressed CD25. The delay in CD8 + T cell proliferation suggested that CD4 + T cell activation might be a prerequisite for CD8 + T cell expansion. To determine whether the CD8 + T cell expansion represented a T cell receptor (TCR)-driven expansion or a nonspecific "bystander" cytokine-driven proliferation of CD8 + T cells, we used peptide:MHC-I tetramers composed of 4 HLA-A*0201 MHC molecules, each bound to a specific 9-mer peptide derived from the HCMV pp65 peptide (NLVPMAVTV) and conjugated with PE [25] , to examine the Ag specificity of the expanding cell populations (figure 2). At day 0, before stimulation, 1.66% and 9.61% of CD8 + T cells obtained from 2 HLA-A*0201 HCMVseropositive donors bound this HCMV pp65-derived tetramer. After 8 days of stimulation with HCMV, there was a 4-5 fold expansion of CD8 + T cells that bound this tetramer, but there was no expansion of CD8 + T cells that bound a tetramer comprised of HLA-A*0201 and a peptide derived from EBV (data not shown). Likewise, although cultivation with tetanus Ag induced proliferation of CD8 + T cells, there was no expansion of CD8 + T cells that bound the HCMV peptide/tetramer complex. Thus, CD8 + T cell proliferation in response to HCMV reflects an expansion of Ag-reactive T cells activated through the TCR. CD8 + T cell proliferative responses require CD4 + T cells. Because CD4 + T cells are important in maintaining Ag-specific CD8 + T cell responses [9, [26] [27] [28] figure 3A and 3B, respectively) . Depletion of CD4 + T cells from the preparation resulted in a failure of CD8 + T cell proliferation in response to both HCMV and tetanus toxoid ( figure 3C ).
Irrelevant Ag can provide help to support HCMV peptidespecific CD8 + T cell proliferation. We found that stimulation with tetanus toxoid Ag provided adequate "help" to support CD8 + T cell proliferation in response to tetanus toxoid, yet did not induce a "bystander" expansion of HCMV-NLV9-binding CD8 + T cells (figure 2). To determine whether an unrelated Ag could induce "help" to expand HCMV-peptide specific CD8 + T cell responses, CFSE-labeled PBMCs were incubated with medium or with tetanus toxoid Ag, and HCMV pp65 NLV9 peptide was added to some wells. Staining with HCMV pp65 495-503 NLV9-PE tetramer showed that the addition of tetanus toxoid supported NLV9-specific CD8 + T cell proliferation ( figure 4B) . Importantly, the addition of NLV9 nonameric peptide alone did not induce CD8 + T cell proliferation in these PBMC preparations, although peptide-binding cells were readily demonstrable in the unstimulated (day 0) preparation (figure 4A). These results indicated that the "help" need not be Ag specific to support CD8 + T cell proliferation. CD8 + T cell proliferation in response to HCMV is blocked by anti-IL-2 but not anti-IL-15 antibody, yet "help" can be provided by either IL-2 or IL-15. To identify potential mechanisms of CD4 + T cell "help" for HCMV-induced CD8 + T cell proliferation, we tested the effects of anti-cytokine MAb in this system. Mouse anti-huIL-2 and mouse anti-huIL-15 were added to PBMC cultures stimulated with HCMV. Expression of CD25 and cell proliferation by CFSE dye dilution were examined after 6 days in culture. MAb to IL-2 reduced proliferation to near background levels, but MAb to IL-15 had no effect ( figure 5A ). These results suggested that IL-2 is necessary to support HCMV-induced CD8 + T cell proliferation, whereas IL-15 was not. To ascertain whether helper cytokines could substitute entirely for CD4 + T cells in supporting CD8 + T cell proliferation in response to HCMV, IL-2 and IL-15 were added to cell cultures depleted of CD4 + T cells (containing !1% contaminating CD4 T cells). Cells characteristic of monocytes, as determined by CD4 +intermediate or CD14 +bright staining, were not depleted by this treatment (data not shown). Addition of IL-2 (3.6 IU/mL) or IL-15 (10 ng/mL) increased background pro- 
liferation of CD4
+ T cell-depleted CD8 + T cells in the absence of Ag. In this experiment, low levels of CD8 + T cell proliferation were seen in response to peptide alone in the CD4 + T celldepleted cultures, but the addition of IL-2 or IL-15 greatly enhanced CD8 + T cell proliferation in response to the NLV9 HCMV peptide (figure 5B). The addition of IL-2 and IL-15 together resulted in only minimal CD8 + T cell proliferation in the absence of exogenous Ag and apparently no additive effects in support of peptide-dependent CD8 + T cell proliferation. Thus, either IL-2 or IL-15 can substitute for CD4 + T cells by providing help for CD8 + T cell proliferation in response to peptide.
HCMV-induced CD8
+ T cell proliferation does not require infectious virus. The HCMV Ag preparation contained infectious virus capable of high-level replication in mink lung fibroblasts (data not shown). Because Ags presented by MHC-I to CD8 + T cells generally are synthesized intracellularly, we wanted to determine whether infectious virus in the Ag preparation was required to induce activation and proliferation of the CD8 + T cells. UV irradiation for 100 min or boiling for 10 min resulted in complete inactivation of HCMV infectivity (data not shown), yet live, UV-inactivated, or heat-inactivated virus preparations induced similar proliferative responses of both CD4 + and CD8 + T cells ( figure 6A ). Thus, neither synthesis of viral proteins nor intact virus structure was required for the proliferation and expansion of CD8 + T cells in response to HCMV. This indicates that cross-presentation of viral Ags (alternate MHC-I processing and presentation) might underlie these findings. To assure that contaminating viral peptides within the cell lysate were not responsible for these results, intact HCMV was purified over a 60% sucrose cushion, washed, and resuspended in PBS at the original starting volume. CD8 + T cell proliferative responses were enhanced by this purification (figure 6B), which indicates that CD8 + T cell proliferation was driven by purified virus and not by contaminating peptide.
DISCUSSION
In the present study, we provide clear evidence that human memory CD8 + T cells proliferate in vitro after exposure to HCMV and that these responses are HCMV peptide specific. CD8 + T cell proliferation also can be seen in response to the soluble Ag tetanus toxoid and killed HCMV, which suggests that Ag cross-presentation drives this response. In this system, CD8 + T cell proliferation is dependent on CD4 + cells. Although both IL-2 and IL-15 can substitute for CD4 + cells, CD4 + T cell help for CD8 + T cell proliferative responses was blocked by MAbs to IL-2 but not by MAbs to IL-15, which indicates that IL-2 plays a central role in this process.
Murine models of viral infection support an important role for CD4 + T cell help in CD8 + T cell responses. For example, in acute lymphocytic choriomeningitis virus (LCMV) infection, CD4 + T cells were not necessary for the generation of virusspecific CD8 + T cells [9, 29, 30] ; however, CD4 + T cells were essential for the expansion and maintenance of virus-specific CD8 + T cell responses during chronic infection [9, [26] [27] [28] ] that led to the resolution of infection [9] . More recently, several reports have suggested that the functional capacity of murine memory CD8 + T cells may depend on the nature and timing of the help that they receive [10] [11] [12] [13] . In these studies, memory CD8 T cell proliferation and cytokine expression were impaired in mice that had first seen Ag in the absence of CD4 + T cell help. Moreover, the secondary expansion of memory CD8 + T cells in response to antigenic challenge did not require CD4 + T cell help at the time of secondary challenge [10] , but, rather, the ability of these memory cells to expand after rechallenge was somehow "programmed" into them through mechanisms dependent on the presence of CD4 + T cells during primary exposure.
In the present study, we examined the secondary memory CD8 + T cell expansion in response to whole HCMV. In all healthy HCMV-seropositive persons studied, memory CD8 + T cell expansion in response to cross-presented HCMV antigens was readily demonstrable. However, in contrast to observations in murine systems, we found that this expansion was critically dependent on the presence of CD4 + T cells. Likewise, MHC-I-restricted CD8 + T cell proliferation responses to inactivated hepatitis B virus (HBV) Ags also were diminished by CD4 + T cell depletion [31] , and, more recently, "effector" CD8 T cell expansion in response to HCMV was shown to be CD4 + T cell dependent [32] . We do not know whether CD4 + T cell help is required for cross-presentation in our system, but CD4 + T cells and/or IL-2 are required for memory CD8 + T cell expansion in response to whole HCMV ( figure 3 and figure 5A ), and CD8 + T cell proliferation in response to the NLV9 HCMV peptide is minimal in the presence or absence of CD4 + T cells ( figure 4B and figure 5B) .
In vivo CD4 + T cell depletion as a result of HIV-1 infection is characterized by dramatic CD8 + T cell dysfunction, such as impaired proliferation, cytokine production, cytolytic activity, and increased anergy and apoptosis [33] [34] [35] [36] [37] [38] [39] . Moreover, in HIV- 
infection, CD8
+ T cell dysfunction probably related to CD4 + T cell dysfunction also may predict clinical outcome. Diminished CD4 + T cell responses to HCMV were associated with an inability to sustain high levels of HCMV-specific CD8 + T cells and an increased risk of HCMV-associated end organ disease [40] . Recently, Migueles et al. [41] showed that the ability of by IL-2, and the requirement for CD4 + T cells could be replaced either by IL-2 or IL-15. The importance of IL-2 in CD8 + T cell expansion is well recognized [32, 42, 43] . The results of the present study demonstrate that, when CD8 + T cell expansion is driven either via the alternative pathways of exogenous Ag presentation or when immunodominant peptide is provided exogenously, IL-2 retains a critical role. Although we could not define a role for IL-15 in CD8 + T cell expansion in our system, we found that IL-15, like IL-2, could substitute for CD4 + T cells for supporting CD8 + T cell expansion in response to HCMV Ags. Additional studies will be required to determine whether the phenotype or function of CD8 + T cells expanded in the presence of CD4 + T cells, IL-2, or IL-15 are distinguishable or whether these sources of help are truly interchangeable. In vivo studies with IL-15-or IL-15R-deficient mice showed normal generation of LCMV-specific memory CD8 + T cells, but, with time, mice deficient in either IL-15 or its receptor had a failure of proliferative renewal of memory CD8 + T cells, and a decline in memory CD8 + T cell numbers [44] . It remains to be determined whether IL-15 plays a similar role in human CD8 + T cell expansion in vivo. Nonetheless, our findings provide some rationale for further exploration of IL-15 and IL-2 as strategies to expand virus-specific CD8 + T cells in persons with CD4 + T cell deficiency. Using intracellular expression of interferon (IFN)-g as a readout and high concentrations of a HCMV infected cell lysate, Maecker et al. [45] recently reported variable degrees of crosspresentation of HCMV Ags to CD8 + T cells of healthy subjects that was inhibited by lactacystin but not by choloroquine, which suggests that this phenomenon was dependent on MHC-I (but not MHC-II) presentation and was also dependent on the presence of HCMV-specific antibodies in the system. We were unable to confirm a role for HCMV-specific antibodies in our system, because CD8 + T cell proliferation in response to whole cytomegalovirus was comparable in the presence of HCMVseropositive and -seronegative serum (data not shown). Moreover, in their studies, as in some of our studies, live virus and other viral Ags were contained within a cell lysate; therefore, it was not clear how much of the observed effect was a result of either viral infection or direct binding of viral peptides contained within the cell lysate. We purified virus from the cell lysate by sucrose density sedimentation to confirm that direct peptide binding without processing and cross-presentation could not account for CD8 + T cell activation and proliferation observed in our system. Buseyne et al. [46] found that crosspresentation of HIV-1 Ags to MHC-I restricted CTL lines and that a T cell clone was dependent on the presence of viral envelope capable of membrane fusion. In contrast, we found that cross-presentation of HCMV peptides was not dependent on the integrity of the virion, because boiling of the HCMV preparation had no effect on cross-presentation to stimulate CD8 + T cell proliferation. In contrast to the reported CD4-independent IFN-g production by CD8 + T cells [45] , we found that CD4 + T cell help was essential to support CD8 + T cell proliferation in response to HCMV Ags. The degree of cellular activation required to induce IFN-g production may be significantly less than the requirements for cellular proliferation [47] [48] [49] , which might explain the differential requirements of these cellular responses for CD4 + T cell help. In summary, memory CD8 + T cells can expand dramatically in vitro in response to whole cytomegalovirus and in response to other exogenous Ags. Cross-presentation of HCMV peptides underlies this expansion that is critically dependent on CD4 + T cell help. Help for cellular expansion is mediated by IL-2, yet both IL-2 and IL-15 can support CD8 + T cell expansion in the absence of CD4 + T cells. The importance of this alternate pathway of Ag presentation during HCMV infection in vivo, as well as in other settings, remains to be determined. This system will provide a valuable model to explore the relationships among antigen-presenting cells, CD4 + T cells, and CD8 + T cells in HCMV disease and HCMV disease complicated by CD4 + T cell deficiency or dysfunction.
